| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |